4D Molecular Therapeutics FDMT
NASDAQ FDMT
$10.80 -1.05 (-8.86%)
At close: Oct 23, 2026 · 4:00 PM EDT

4D Molecular Therapeutics (FDMT) Sale and Maturity of Investments (2021 - 2026)

Updated

Analysis

4D Molecular Therapeutics (FDMT) Sale and Maturity of Investments (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 4D Molecular Therapeutics 758.94 Mn -701.01 Mn - 87.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 87.65 Mn
Mar 31, 2026 102.40 Mn
Dec 31, 2025 49.18 Mn
Sep 30, 2025 32.93 Mn
Jun 30, 2025 101.62 Mn
Mar 31, 2025 166.66 Mn
Dec 31, 2024 65.79 Mn
Sep 30, 2024 64.87 Mn
Jun 30, 2024 23.57 Mn
Mar 31, 2024 14.78 Mn
Dec 31, 2023 28.51 Mn
Sep 30, 2023 30.39 Mn
Jun 30, 2023 55.52 Mn
Mar 31, 2023 58.87 Mn
Dec 31, 2022 -135.19 Mn
Sep 30, 2022 205.28 Mn
Jun 30, 2022 65.72 Mn
Mar 31, 2022 12.00 Mn
Dec 31, 2021 5.00 Mn
API Access

4D Molecular Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=FDMT&period=max&api_key=YOUR_API_KEY